Lifetime Achievement Award for Professor Gordon Amidon

The Frankfurt Foundation Quality of Medicines will present this year’s Lifetime Achievement Award to Prof. Dr. Gordon L. Amidon of the University of Michigan, USA.

The award is in recognition of Professor Amidon’s exceptional achievements in the field of pharmaceutical sciences and his outstanding contributions to improving the quality and efficacy of medicinal products.

The award ceremony will take place during the symposium “Advances in Predictive Biopharmaceutics, Drug Product Quality and Patient Benefit”, which is jointly organized by the Johann Gutenberg University and the Frankfurt Foundation Quality of Medicines and will take place on 11 July 2025 in Mainz (link to the conference program: https://ak-lang.pharmazie.uni-mainz.de/ffqm-jgu-symposium/

Gordon Amidon’s scientific contributions have improved the understanding of drug absorption and significantly influenced the assessment of generic equivalence through in vitro studies. He was instrumental in the development of the Biopharmaceutical Classification System (BCS) and its implementation as a BCS-based biowaiver concept. Today, the BCS is used worldwide in the development of solid oral dosage forms

Professor Amidon has received numerous awards for his scientific work. He has authored over 400 scientific articles and book chapters and supervised more than 120 PhD students and postdoctoral fellows. Amidon was the founder and long-standing editor-in-chief of the scientific journal “Molecular Pharmaceutics”.

Previous winners of the Frankfurt Foundation Quality of Medicines Lifetime Achievement Award are

Prof. Dr. Laszlo Endrenyi, Department of Pharmacology & Toxicology, University of Toronto/Canada (2021),

Prof. Dr. José Augusto Guimarães Morais, Department of Pharmacological Sciences, Faculty of Pharmacy, University of Lisbon/Portugal (2021),

Professor Dr. Leslie Z. Benet, Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California, San Francisco/USA (2023) and

Professor A. Atilla Hincal, Pharmaceutical Technology, Hacettepe University, Ankara/Turkey (2024).